Autism Spectrum Disorders



Autism Spectrum Disorders


Reet K. Sidhu



INTRODUCTION

Autism spectrum disorders (ASD) are a heterogeneous group of biologically based neurodevelopmental disorders of brain function. They are a behaviorally defined group of disorders that are characterized by impairments in two areas: (1) deficits in social communication and social interactions and (2) restricted and repetitive patterns of behavior, interests, and activities. The term autism (originating from the Greek word autos meaning self) was adopted by Leo Kanner in 1943 to describe children whose behavior was “governed rigidly and consistently by the powerful desire for aloneness and sameness.”

The ASDs have been defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM) of the American Psychiatric Association under many different names including the umbrella term pervasive developmental disorder or PDD, causing much confusion for both families and professionals. With the most recent 2013 revision, Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), ASD now subsumes what were previously separate diagnostic categories of autistic disorder (also referred to as classic autism or early infantile autism), pervasive developmental disordernot otherwise specified (PDD-NOS), and Asperger syndrome. These changes are based on research results which have failed to document these categories as separate biologic entities.

Under the DSM-5, a diagnosis of ASD requires an individual to exhibit three deficits in social communication and at least two symptoms in the category of restricted range of activities/repetitive behaviors. The prior version of the diagnostic manual also included deficits in language expression as a separate criterion, but this is no longer the case, as not all children with ASD have specific language disorders. Pragmatic language skills, however, are incorporated into the social domain, as all individuals with ASD have deficits in this domain of language. Within the second category, a new symptom is included: hyper- or hyporeactivity to sensory input or unusual interests in sensory aspects of the environment. Deficits in social communication and interactions include those in social reciprocity; nonverbal communication; and skills in developing, maintaining, and understanding relationships. Symptoms must be present in early development but need not be shown until social demands exceed the individual’s capacity. Furthermore, DSM-5 specifies three levels of severity (mild, moderate, severe) rated separately for social communication and restricted, repetitive behaviors based on what level of support the individual requires. In addition to the diagnosis, individuals are also described in terms of any known genetic cause (e.g., fragile X syndrome, Rett syndrome), level of language and intellectual disability, and presence of medical conditions such as seizures, psychiatric disorders (e.g., anxiety, depression), and/or gastrointestinal disorders. The variability in severity and range of disabilities seen in children with ASD cannot be overemphasized. A full description of the DSM-5 criteria for ASD can be found in the American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 5th edition.


EPIDEMIOLOGY

There has been a significant increase in the prevalence of ASD in the United States, particularly since the late 1990s when the estimated frequency was about 1 per 1,000 for autism and 2.8 per 1,000 for all ASD subtypes (autistic disorder, Asperger syndrome, and PDD-NOS). The estimated prevalence is much higher now. The Autism and Developmental Disabilities Monitoring Network (2010, 2014) that identifies ASD through screening and review of health and education records that document behaviors associated with ASD in 11 sites in the United States most recently reported a prevalence rate of 14.7 per 1,000 (1 in 68) among 8-year-olds, with prevalence estimates varying from 5.7 to 21.9 per 1,000 in the different sites. Non-Hispanic white children were approximately 30% more likely to be identified with ASD than non-Hispanic black children and almost 50% more than Hispanic children. ASDs are four times more likely in males than in females.

Factors such as increased awareness among parents and professionals, broadening of the diagnosis with emphasis on the spectrum aspect of the disorder, including mildly affected individuals, change in referral patterns, and using the diagnosis as a basis for intervention services may account for increased prevalence rates. The theory that vaccines, in particular the measles, mumps, rubella (MMR) vaccine, play any role in the increased prevalence of autism has been completely discredited.


PATHOBIOLOGY


NEUROPATHOLOGY

ASDs are characterized as neurodevelopmental disorders because their signs and symptoms have been demonstrated to be the result of alterations in brain structure and function. Although much remains to be discovered, a great deal is now known about the fundamental alterations in the brain in ASD. ASDs are now considered disorders of the development of connectivity of neurons of cerebral cortex, which results in disturbances in the highly specialized connections that provide for uniquely human abilities. Studies of brain structure have implicated multiple events in prenatal and postnatal brain development, particularly neuronal organizational events. The generalized enlargement of the brain resulting from premature overgrowth attests to the broadness of the involvement of the brain, precluding focal brain theories and single primary deficit theories. The occurrence of mutations in genes that act on molecular signaling pathways involved in the development and maintenance of neuronal and synaptic connections have reinforced the centrality of disruption of cortical connectivity in ASD.

The most consistent abnormality seen on neuroimaging studies and in postmortem examination is an increase in brain weight and volume in children with ASDs compared to controls. Very young children with ASD (18 months to 4 years) have a 5% to 10% increase in brain volume, especially in the frontal lobe, which
parallels the increasing head circumference during this period. By adolescence and adulthood, however, brain volumes seem to be lower than in controls, suggesting brain overgrowth within the first few years of life followed by volume loss. Increased brain volume in childhood is attributed primarily to enlargement of white matter, specifically the corona radiata and U-fibers, whereas the size of the corpus callosum is reduced, perhaps resulting in decreased interhemispheric communication. The white matter abnormalities result in abnormality of connectivity. At the cytoarchitectonic level, minicolumns that determine connectivity are abnormal, especially in the dorsolateral prefrontal cortex. As a result, and well delineated on diffusion tensor (DT) imaging, short-range connectivity is increased, and long-range connectivity is decreased. The hyperconnected local networks may become partially isolated and acquire novel functional properties. By contrast, the decrease in long-range connections could explain the problems with top-down control and integration.

Imaging studies also highlight the dissociation between white matter tract overgrowth and gray matter dendritic and synaptic underdevelopment. Also found is an enlargement of the cerebellum and caudate nuclei. Larger caudate volumes are associated with more severe stereotyped motor mannerisms. Volumes of the amygdala and hippocampus have been more variable. In addition to showing an increase in short-range connectivity and decrease in long-range connectivity, DT imaging also demonstrates an alteration of white matter tracts in brain regions implicated in social cognition, including the fusiform gyrus, superior temporal gyrus, ventromedial prefrontal cortex, anterior cingulate, and temporoparietal junction. Magnetic resonance (MR) spectroscopy studies suggest that gray matter is abnormal and dendritic arborization and synaptosome density reduced with lower levels of neuronal N-acetylaspartate and alterations in choline and creatinine metabolism.

Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) suggest reduced brain perfusion and abnormalities of serotonin synthesis. Functional imaging studies (functional magnetic resonance imaging [fMRI]) have shown atypical patterns of brain activation during tasks of face processing, language, and emotional understanding. Activation of the mirror neuron system—a network within the inferior frontal gyrus and posterior parietal lobe that is thought to subserve imitation and understanding of intentions of other people—is reduced in individuals with ASDs, suggesting a role for this network in the pathogenesis of autism.

Neuropathologic studies have generally consisted of few subjects, but postmortem abnormalities include inflammatory changes and reduced width and increased number of cortical minicolumns compared with controls. A recent postmortem study supports a prenatal onset of ASD occurring during the second and third trimester of pregnancy. Focal patches of abnormal laminar cytoarchitecture and cortical disorganization of neurons, but not glia, were found in the prefrontal and temporal cortical tissue from 10 of 11 children with autism and from 1 of 11 unaffected children, supporting a probable dysregulation of layer formation and layerspecific neuronal differentiation prenatally.


GENETICS

ASDs are clinically and etiologically heterogeneous. Twin and family studies provide evidence for ASD as a highly genetic disorder with heritability estimates of 85% to 92%. Genetic heterogeneity is suspected. Using currently available technology, a genetic cause can be identified in 30% to 40% of children with ASD. This number has increased with the use of chromosomal microarrays (CMAs).

Known genetic causes of ASD include cytogenetically visible chromosomal abnormalities (5%), copy number variants (CNVs) (e.g., submicroscopic deletions and duplications) (10% to 20%), and single gene disorders in which neurologic findings are associated with ASD (5%). CMA is rapidly replacing high-resolution chromosomes as the initial test of choice to evaluate children with ASD. CMA has identified clinically relevant de novo genetic imbalances in up to 20% of individuals with autism of unknown cause. The most common autism-related CNVs are the 15q11.2-11.3 duplications, reciprocal 16p11.2 microdeletions and duplications, and the 7q11.23 duplication. Taken together, these CNVs seem to confer susceptibility to ASD in up to 1% of individuals. A number of other CNVs have been described in a few autism families, and although none seems to be particularly common, they highlight the potential of array-based techniques to point autism researchers toward specific autism genes within the CNVs.

The microarray technology is evolving with more advanced types of arrays, including those used in research studies, picking up more and smaller CNVs. Unfortunately, it is often not possible to know whether many of the small CNVs are pathologic or benign. In some cases, a variant might be reported that has no known phenotypic consequence or that the consequence is not known to be related to the ASD. Parental testing is frequently performed to assist in interpretation of abnormal findings. Informed genetic counseling is very important in this context. Children identified with CNVs of unclear significance should be followed periodically by the geneticist so new information can be shared with the family as it becomes available. It should be noted that CMA will not detect balanced translocations or low-level mosaicism; a karyotype should be done when there is a family history of multiple miscarriages or there is high suspicion of mosaic aneuploidy.

For individuals with ASD in whom the etiology is known, genetic counseling and risk assessment are based on the genetics of that specific disorder. For ASD of unknown cause, the empiric aggregate risk to siblings is 5% to 10% for autism and 10% to 15% for milder conditions including language, social, and psychiatric disorders. For families with two or more affected children, the recurrence risk approaches 35%. Recurrence risk may be up to 20% for families who have one autistic child plus another child or relative with mild autistic symptoms. The amount of weight to place on mild autistic symptoms in siblings, parents, and other relatives when estimating recurrence risk for families is unknown. Families contemplating additional pregnancies should be offered genetics evaluation and counseling by a medical geneticist.

In addition to clinically identifying known genetic disorders which may predispose to ASD, intense efforts have been directed to identifying genes that specifically cause or increase the risk of developing ASD. Methods used include both large genome-wide association studies and investigation of candidate genes. A number of genes of interest, including neuroligin 3 and 4, neurexin 1, contactin 4, contactin-associated protein-like 2, and SHANK 3, play a role in synapse formation and function. Other genes have a role in serotonin, glutamate, or γ-aminobutyric acid (GABA) neurotransmission. This is an area of tremendous interest in the scientific community and is rapidly evolving.


CLINICAL FEATURES

Social communication dysfunction is the hallmark of ASDs. Deficits in sociability are variable but an essential and defining feature. Early signs include failure to respond to name, abnormal eye gaze (gaze aversion), paucity of gestures, and impairment of
joint attention (the ability to draw another person’s attention to an object of interest through the use of eye gaze and gestures, such as pointing). Children appear aloof with a lack of interest in others and mainly interact with others when they need something rather than to share their interests, enjoyment, and achievements. As children age, a lack of empathy becomes apparent along with difficulty interpreting and reciprocating the social and emotional behaviors of others. Pragmatic language skills are always impaired, that is, the social rules for communicating are not well understood. These individuals have a hard time taking turns in conversations, talk only about topics of their interest or knowledge, talk at people without checking to see if anyone is listening or interested, fail to maintain appropriate interpersonal distance, and are inappropriately intrusive or persistent. There is an impaired ability to read facial expressions, body language, and tone of voice of others, which contributes to these deficits. They are often described as “odd” or “annoying,” as their social approaches are peculiar.

Another cardinal feature of ASD is a restricted range of behaviors, interests, and activities that are often repetitive or stereotyped. These include motor stereotypies such as hand flapping or licking, finger flicking, spinning, and body rocking. They may have unusual preoccupations and interests and play skills are impaired. These children can watch the same video for hours, play with unusual objects (e.g., a piece of string), or line up toys instead of playing with them imaginatively. Some children have routines or rituals that need to be followed and many such children have difficulty making transitions. Overall, there is a tolerance for monotony and a resistance to change.

Although no longer a criterion for a diagnosis of ASD, verbal communication disturbances are commonly found. The most common presenting complaint is a delay in language development. Despite this delay, there is a lack of compensation through nonverbal modes of communication, such as gesture and imitation. Spoken language is often echolalic with repetitive and stereotyped phrases. Some children will recite scripts from television or videos. Some children fail to process language and despite normal hearing, appear deaf (verbal auditory agnosia). Abnormalities in syntax (word order), semantics (word meaning), and most prominently pragmatics are present in higher functioning individuals. These children are often extremely literal and concrete and have difficulties understanding jokes, humor, or sarcasm. Speech prosody (melody of language) is impaired, as evidenced by mechanical, monotonous, excessively rapid, high-pitched, and high-volume speech. There can be a fascination with letters and numbers in the early toddler years and some children may learn to read without instruction, e.g. hyperlexia, although comprehension is limited.

Intelligence is not a defining feature but strongly influences prognosis. Intellectual disability (IQ <70) occurs in approximately 55% of individuals with ASD, although many have average or even superior intellectual ability. Prodigious or savant skills can be seen in visuospatial ability, memory, calculation, or music ability. IQ is a key predictor of long-term outcome in autism, especially for those with an IQ of less than 50 who generally fare poorly. Average to superior IQ is a positive prognostic sign. Having a higher verbal IQ at 2 to 3 years of age appears to predict better outcome, particularly if intervention is delivered early.

Developmental regression or loss of previously established skills during the first 1 to 3 years of life has been estimated as occurring in approximately one-third of children with ASD. There is debate as to whether children with ASD and regression develop better, worse, or the same on IQ, language, and social functioning than those with no regression, but good recovery in children with regressive symptoms is rare.


MEDICAL COMORBIDITIES

Medical comorbidities frequently occur in ASD. Among them include epilepsy, gastrointestinal dysfunction, sleep disorders, and psychiatric conditions (e.g., anxiety, depression, obsessivecompulsive disorder [OCD]). It is important to consider medical causes for any change in behavior, especially in those individuals who are nonverbal or with limited language capability. Examples of such medical conditions include, but are not limited to, the following: pain (due to migraine headaches, ear infection, fractures, etc.), gastrointestinal disorders (e.g., gastroesophageal reflux disease [GERD], constipation), genitourinary conditions (e.g., urinary tract infection [UTI]), hormonal imbalance/endocrine dysfunction (e.g., menstruation), and sleep disturbance (e.g., sleep apnea).


EPILEPSY

The association of epilepsy with autism provided one of the first clues to suggest that autism was a neurodevelopmental disorder of brain function. It is now well established that individuals with ASD have a higher risk of epilepsy as compared with the general population. Epilepsy is commonly reported to occur in approximately one-third of individuals with ASD but the exact prevalence is unknown with reports in the literature ranging from 5% to 50%. Variation in estimates is likely related to multiple factors such as sample ascertainment, degree of intellectual disability, age, gender, and type of ASD (idiopathic vs. complex). Intellectual disability and motor impairments (e.g., cerebral palsy) have been identified most commonly as significant risk factors for epilepsy in ASD, with higher rates in those with more severe cognitive impairments. A community-based study of ASD in children with epilepsy has found that only 5% to 15% of children with epilepsy have autism.

Age of onset of epilepsy in ASD has generally been thought to occur in two peaks, one in early childhood (0 to 5 years) and the other in adolescence (10 to 15 years). The peak before age 5 years, however, includes those children with ASD secondary to infantile spasms (frequently as part of tuberous sclerosis) and other epileptic encephalopathies.

Given the prevalence of epilepsy in autism, it is important to consider the possibility of seizures when evaluating an individual with autism but currently, there is inadequate evidence to recommend electroencephalogram (EEG) in all individuals with autism. Although all seizure types are present in ASD, the most commonly observed are complex partial seizures (85%) and generalized tonic-clonic seizures (7%). Absence and myoclonic seizures occur less commonly (1% to 4%).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 27, 2016 | Posted by in NEUROLOGY | Comments Off on Autism Spectrum Disorders

Full access? Get Clinical Tree

Get Clinical Tree app for offline access